PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9
$116,867N01FY2019CANIH
University Of Arizona, Tucson AZ
Investigators
Abstract
The contractor will conduct a phase II randomized, placebo-controlled, double-blind trial of PROSTVAC? in patients with clinically localized prostate cancer undergoing active surveillance to assess the immunological (primary) and clinical (secondary) response to this vaccine.
View original record on NIH RePORTER →